First-In-Human, Multicenter Study of SENTI-202, a CD33/FLT3 Selective Off-the-Shelf Logic Gated CAR NK Cell Therapy in Hematologic Malignancies including AML: Correlative Data

AACR Annual Meeting
Muharrem Muftuoglu, Enping Hong, Stephen A. Strickland, Alireza Eghtedar, Gary Schiller, Nosha Farhadfar, Ashish R. Bajel, Farhad Ravandi, Mahesh Basyal, Li Li, Lawrence Naitmazi, Rochelle Emery,Brian S. Garrison, Timothy Lu, Kanya Rajangam, Michael Andreeff